Home » Ajax Engineering IPO Complete Overview » Ajax Engineering IPO GMP (Grey Market Premiums)

Ajax Engineering IPO (Ajax Engineering Limited IPO)

Ajax Engineering IPO GMP

Ajax Engineering IPO issue price is 629, the latest GMP is ₹11 and the estimated listing price is ₹640(1.75%). Ajax Engineering IPO opens on 10 February 2025 and closes on 12 February 2025. Ajax Engineering IPO will be listed on 17 February 2025.

Day-wise Ajax Engineering IPO GMP trends:

GMP DateIPO Price(₹)GMP(₹)Est. Listing Price(₹)Last Updated
16-02-202562911640(1.75%)16 Feb 04:16 PM
15-02-202562911640(1.75%)15 Feb 09:19 AM
14-02-202562911640(1.75%)14 Feb 09:48 AM
13-02-202562911640(1.75%)13 Feb 09:23 AM
12-02-20256290629(0%)12 Feb 09:13 AM
11-02-202562960689(9.54%)11 Feb 09:38 AM
10-02-202562960689(9.54%)10 Feb 03:00 AM

Check IPO GMP Dashboard

**For better insights and Review of IPO check IPO Pulse Score

Frequently Asked Questions

What is the Grey Market Premium (GMP) for Ajax Engineering IPO?

The Ajax Engineering IPO GMP indicates the grey market trading price of shares compared to their issue price. As of 16th February 2025, the GMP is ₹11.

How does GMP affect Ajax Engineering IPO listing price?

The GMP suggests the estimated listing price. For Ajax Engineering IPO, the current estimated listing price is ₹640 based on the ₹629 issue price.

Is the Ajax Engineering IPO GMP reliable?

GMP is based on market sentiment and news, so while it offers insights, it is not an official financial indicator.

Where can I track the latest Ajax Engineering IPO GMP?

You can follow the latest GMP trends on IPO Reporter for daily updates.

When will Ajax Engineering IPO be listed?

The Ajax Engineering IPO will be listed on 17th February 2025.

The Grey Market Premium indicates the demand for IPO shares in the grey market before they get listed on the stock exchange. It reflects the price at which shares are being traded in the grey market, compared to their issue price. A higher GMP suggests strong investor interest and a potentially successful listing. Stay informed with the latest GMPs of ongoing and upcoming IPOs to make well-informed investment decisions.

Disclaimer: